| Zugriffe | |
|---|---|
| Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ) | 67 |
| Juni 2025 | Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | |
|---|---|---|---|---|---|---|---|
| Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ) | 0 | 0 | 0 | 0 | 0 | 65 | 2 |
| Zugriffe | |
|---|---|
| 2023_Chekerov_etal.pdf | 9 |
